查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1825941

2025 年全球無晶體眼市場報告

Aphakia Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，無晶體眼市場規模迅速擴張，從2024年的16.8億美元成長至2025年的18.9億美元，複合年成長率達12.3%。這段時期的成長歸因於白內障盛行率的上升、先進手術技術的進步、眼部健康意識的增強、眼科手術數量的增加以及臨床檢查數量的增加。

預計未來幾年無晶體眼市場將快速成長，到2029年將達到30.1億美元，複合年成長率為12.3%。預測期內的成長歸因於對先進人工水晶體(IOL)的需求不斷成長、眼科手術數量不斷增加、眼外傷患病率不斷上升、眼科手術醫療旅遊的興起以及對個性化治療方案的日益關注。預測期內的主要趨勢包括數位技術在白內障手術中的整合、微創手術技術的進步、晶狀體材料的改進、患者個性化數據分析的引入以及機器人輔助手術的普及。

無晶體眼是指眼晶狀體有缺陷，可能導致嚴重的視力障礙，因為水晶體在將光線聚焦到視網膜方面起著至關重要的作用。這種疾病可能由手術摘除水晶體（白內障手術或其他手術）、外傷或其他導致自然水晶體喪失的疾病所引起。

無晶體眼市場主要分為三大類：先天性無晶體眼、手術性無晶體眼及後天性無晶體眼。先天性無晶體眼是指出生時單眼或雙眼缺乏水晶體。治療方法，包括框架眼鏡、隱形眼鏡、人工水晶體植入和屈光矯正手術，最終用戶包括醫院和眼科診所。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療保健領域產生了重大影響，尤其是對基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正疲於應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本，而這些產品中的許多在國內的替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力，一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，導致供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供了無晶狀體市場統計數據，例如全球市場規模、區域佔有率、市場佔有率佔比較高的競爭對手、詳細的無晶狀體市場細分、市場趨勢以及無晶狀體行業的商機，為您提供在無晶狀體行業取得成功所需的數據。本無晶體市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供全面的觀點，助您一臂之力。

未來五年12.3%的成長率預測比我們先前的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會對美國眼科手術構成重大挑戰，因為它會限制從以色列和德國進口的高階人工水晶體和無晶體眼接觸鏡的獲取，從而可能損害視力康復效果並增加白內障手術的成本。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，其影響也將更加廣泛。

白內障盛行率的不斷上升預計將推動未來無晶體眼市場的成長。白內障是指眼球水晶體變得混濁，導致視力模糊的一種疾病。導致白內障發病率上升的因素包括人口老化、糖尿病盛行率上升、過度日曬、吸菸和營養不良。白內障會導致無晶體眼，需要透過手術摘除眼球的天然水晶體，去除混濁的水晶體。例如，根據《未來世代福祉法案》（WFG）進行的英國眼科統計調查（2021-2023 年）的數據，2022 年至 2023 年，英國住院的白內障患者人數約為 16,500 人，比前一年增加了 23.7%。因此，白內障發病率的上升正在推動無晶體眼市場的發展。

無晶體眼市場的主要參與企業正在開發用於矯正老花眼的人工水晶體(IOL)，旨在改善視力結果並提高患者滿意度。這些人工水晶體透過恢復視力和矯正老花眼來幫助無晶體眼患者，使他們無需額外佩戴眼鏡即可在不同距離獲得清晰的視力。例如，2023 年 11 月，瑞士手術設備公司愛爾康 (Alcon) 在加拿大推出了 Clareon Vivity。這款創新的非衍射、擴展景深 (EDOF) 人工水晶體可最大限度地減少視力障礙並提供高品質的視覺。 Clareon Vivity IOL 專為治療無晶體眼而設計，無晶體眼是由於白內障手術中摘除自然水晶體而導致的疾病。它採用 X-wave 技術進行聚焦而不會分裂波前，從而最大限度地減少光暈並提供更準確的視覺體驗。這項進步標誌著無晶體眼市場向前邁出了重要一步，為白內障患者提供了更好的老花眼矯正解決方案。

2024年7月，美國眼科護理服務供應商iCare Health Solutions收購了Beraja Medical Group，收購金額未揭露。此次收購旨在拓展iCare Health Solutions的眼科護理服務，並改善病患治療效果。此次收購旨在提升優質醫療服務的可近性，同時將iCare的成熟專業技術整合到iCare網路中。此外，收購還確保了本地業務永續營運，並為當地居民保留了熟悉的員工隊伍。 Beraja Medical Group專注於綜合眼科，專注於先進的眼科護理和美容服務，包括與無晶體眼相關的服務。

無晶體眼市場由提供診斷、人工人工水晶體(IOL) 手術植入、術後護理和復健等服務的營業單位所獲得的收益所構成。市場規模還包括服務提供者銷售的或包含在其服務產品中的任何相關產品的價值。無晶體眼市場還包括人工水晶體(IOL)、隱形眼鏡、眼鏡和眼部植入的銷售。此市場價值是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球無晶體症：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球無水晶體眼市場：成長率分析
  • 全球無晶體眼市場表現：規模與成長，2019-2024 年
  • 全球無晶體眼市場預測：2024-2029 年、2034 年規模與成長
  • 全球無晶體眼：總潛在市場（TAM）

第6章 市場細分

  • 全球無晶體眼市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 先天性無晶體
  • 手術性無晶體眼
  • 後天無晶體眼
  • 全球無晶體眼市場（依治療、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 眼鏡
  • 隱形眼鏡
  • 人工水晶體植入術
  • 屈光矯正手術
  • 全球無晶體眼市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 眼科診所
  • 其他
  • 全球無晶體市場：先天性無晶體細分、類型、表現及預測（2019-2024、2024-2029、2034）
  • 原發性無晶體眼
  • 繼發性次發性眼
  • 全球無晶體眼市場：手術性無晶體眼細分市場、按類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 白內障手術後
  • 水晶體脫位手術後
  • 全球無晶體眼市場：按類型、績效和預測分類的無晶體眼細分市場，2019-2024 年、2024-2029 年、2034 年
  • 外傷性無晶體症
  • 疾病引起的無晶體症

第7章 區域和國家分析

  • 全球無晶體眼市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球無晶體眼市場：按國家/地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 無晶體市場：競爭格局
  • 無晶體市場：公司簡介
    • Johnson & Johnson Services Inc.
    • Aetna Inc.
    • Alcon Laboratories Inc.
    • Hoya Corporation
    • CooperVision Inc.

第31章：其他領先和創新企業

  • Carl Zeiss AG
  • Santen Pharmaceutical Co. Ltd.
  • Appasamy Associates
  • Aurolab
  • Rayner Intraocular Lenses Limited
  • VSY BIoTechnology
  • Ophtec BV
  • SIFI SpA
  • Aaren Scientific Inc.
  • Mediphacos
  • Hanita Lenses Ltd.
  • Menicon Co. Ltd.
  • Lenstec Inc.
  • Morcher GmbH
  • Bausch & Lomb Incorporated

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年無水晶體市場：提供新機會的國家
  • 2029 年無晶體市場：細分領域帶來新機會
  • 2029 年無晶體市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r31605u

Aphakia is defined as the absence of the crystalline lens in the eye, which can result in significant visual impairment since the lens plays a vital role in focusing light onto the retina. This condition may arise from the surgical removal of the lens (such as during cataract surgery), trauma, or other medical conditions that result in the loss of the natural lens.

The primary categories within the aphakia market include congenital aphakia, surgical aphakia, and acquired aphakia. Congenital aphakia describes a condition present at birth, where an individual is born without a natural lens in one or both eyes. Various treatment options are available, including spectacles, contact lenses, intraocular lens implantation, and refractive surgery, with end users comprising hospitals, ophthalmic clinics, and other facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The aphakia market research report is one of a series of new reports from The Business Research Company that provides aphakia market statistics, including aphakia industry global market size, regional shares, competitors with a aphakia market share, detailed aphakia market segments, market trends, and opportunities, and any further data you may need to thrive in the aphakia industry. This aphakia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aphakia market size has grown rapidly in recent years. It will grow from $1.68 billion in 2024 to $1.89 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increasing prevalence of cataracts, growth in advanced surgical techniques, increasing awareness about eye health, rising number of eye surgeries, increasing number of clinical trials.

The aphakia market size is expected to see rapid growth in the next few years. It will grow to $3.01 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing demand for advanced intraocular lenses (IOLs), growth in ophthalmic surgical procedures, increasing prevalence of eye trauma, growth in medical tourism for eye surgeries, increasing focus on personalized treatment options. Major trends in the forecast period include integration of digital technology in cataract surgery, advancements in minimally invasive surgical techniques, advancements in lens materials, implementation of patient specific data analytics, adoption of robotic assisted surgery.

The forecast of 12.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. ophthalmic surgery by restricting access to premium intraocular lenses and aphakic contact lenses imported from Israel and Germany, potentially compromising visual rehabilitation outcomes and increasing cataract surgery costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of cataracts is anticipated to drive the growth of the aphakia market in the future. Cataracts are a condition in which the lens of the eye becomes opaque, resulting in blurred vision. Factors contributing to the rise in cataract cases include an aging population, a higher prevalence of diabetes, excessive sun exposure, smoking, and inadequate nutrition. The condition leads to aphakia, as surgery to remove the cloudy lens necessitates the extraction of the eye's natural lens. For example, data from the National UK Eye Care Statistics Survey (2021-2023), conducted by the Well-being of Future Generations Act (WFG), revealed that there were approximately 16,500 cataract admissions in the UK during 2022-2023, reflecting a 23.7% increase from the prior year. Consequently, the growing occurrence of cataracts is boosting the aphakia market.

Key players in the aphakia market are developing presbyopia-correcting intraocular lenses (IOLs) aimed at improving visual outcomes and enhancing patient satisfaction. These IOLs assist individuals with aphakia by restoring vision and correcting presbyopia, allowing clear vision at various distances without the need for additional eyewear. For instance, in November 2023, Alcon, a surgical equipment company based in Switzerland, introduced the Clareon Vivity in Canada. This innovative nondiffractive extended depth of focus (EDOF) IOL delivers high-quality vision with minimal visual disturbances. The Clareon Vivity IOL is specifically designed for treating aphakia, a condition arising from the removal of the natural lens during cataract surgery. By employing x-wave technology, it enhances focus without splitting the wavefront, thus minimizing halos and providing a more precise visual experience. This advancement represents a significant step forward in the aphakia market, offering cataract patients an improved solution for presbyopia correction.

In July 2024, iCare Health Solutions, a US-based ocular care services provider, acquired Beraja Medical Group for an undisclosed sum. This acquisition aims to broaden iCare Health Solutions' eyecare offerings and enhance patient outcomes. The initiative seeks to improve access to high-quality care while integrating established expertise into iCare's network. Additionally, it ensures the continuation of local operations and maintains familiar staff for the community. Beraja Medical Group specializes in comprehensive ophthalmology, with a focus on advanced eye care and aesthetic services, including those related to aphakia.

Major companies operating in the aphakia market are Johnson & Johnson Services Inc., Aetna Inc., Alcon Laboratories Inc., Hoya Corporation, CooperVision Inc., Carl Zeiss AG, Santen Pharmaceutical Co. Ltd., Appasamy Associates, Aurolab, Rayner Intraocular Lenses Limited, VSY Biotechnology, Ophtec BV, SIFI SpA, Aaren Scientific Inc., Mediphacos, Hanita Lenses Ltd., Menicon Co. Ltd., Lenstec Inc., Morcher GmbH, Bausch & Lomb Incorporated, Bohus BioTech AB, Nidek Co. Ltd., Swiss Advanced Vision AG, UltraVision CLPL, Medennium Inc.

North America was the largest region in the aphakia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aphakia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aphakia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aphakia market consists of revenues earned by entities by providing services such as diagnosis, surgical implantation of intraocular lenses (IOLs), postoperative care, and rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The aphakia market also includes sales of intraocular lenses (IOLs), contact lenses, spectacles, and ocular implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aphakia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aphakia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aphakia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The aphakia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Congenital Aphakia; Surgical Aphakia; Acquired Aphakia
  • 2) By Treatment: Spectacles; Contact Lenses; Intraocular Lens Implantation; Refractive Surgery
  • 3) By End User: Hospitals; Ophthalmic clinics; Other End Users
  • Subsegments:
  • 1) By Congenital Aphakia: Primary Aphakia; Secondary Aphakia
  • 2) By Surgical Aphakia: Post-Cataract Surgery; Post-Lens Dislocation Surgery
  • 3) By Acquired Aphakia: Trauma-Induced Aphakia; Disease-Induced Aphakia
  • Companies Mentioned: Johnson & Johnson Services Inc.; Aetna Inc.; Alcon Laboratories Inc.; Hoya Corporation; CooperVision Inc.; Carl Zeiss AG; Santen Pharmaceutical Co. Ltd.; Appasamy Associates; Aurolab; Rayner Intraocular Lenses Limited; VSY Biotechnology; Ophtec BV; SIFI SpA; Aaren Scientific Inc.; Mediphacos; Hanita Lenses Ltd.; Menicon Co. Ltd.; Lenstec Inc.; Morcher GmbH; Bausch & Lomb Incorporated; Bohus BioTech AB; Nidek Co. Ltd.; Swiss Advanced Vision AG; UltraVision CLPL; Medennium Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Aphakia Market Characteristics

3. Aphakia Market Trends And Strategies

4. Aphakia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Aphakia Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Aphakia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Aphakia Market Growth Rate Analysis
  • 5.4. Global Aphakia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Aphakia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Aphakia Total Addressable Market (TAM)

6. Aphakia Market Segmentation

  • 6.1. Global Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Congenital Aphakia
  • Surgical Aphakia
  • Acquired Aphakia
  • 6.2. Global Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spectacles
  • Contact Lenses
  • Intraocular Lens Implantation
  • Refractive Surgery
  • 6.3. Global Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ophthalmic clinics
  • Other End Users
  • 6.4. Global Aphakia Market, Sub-Segmentation Of Congenital Aphakia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Primary Aphakia
  • Secondary Aphakia
  • 6.5. Global Aphakia Market, Sub-Segmentation Of Surgical Aphakia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Post-Cataract Surgery
  • Post-Lens Dislocation Surgery
  • 6.6. Global Aphakia Market, Sub-Segmentation Of Acquired Aphakia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Trauma-Induced Aphakia
  • Disease-Induced Aphakia

7. Aphakia Market Regional And Country Analysis

  • 7.1. Global Aphakia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Aphakia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Aphakia Market

  • 8.1. Asia-Pacific Aphakia Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Aphakia Market

  • 9.1. China Aphakia Market Overview
  • 9.2. China Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Aphakia Market

  • 10.1. India Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Aphakia Market

  • 11.1. Japan Aphakia Market Overview
  • 11.2. Japan Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Aphakia Market

  • 12.1. Australia Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Aphakia Market

  • 13.1. Indonesia Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Aphakia Market

  • 14.1. South Korea Aphakia Market Overview
  • 14.2. South Korea Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Aphakia Market

  • 15.1. Western Europe Aphakia Market Overview
  • 15.2. Western Europe Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Aphakia Market

  • 16.1. UK Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Aphakia Market

  • 17.1. Germany Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Aphakia Market

  • 18.1. France Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Aphakia Market

  • 19.1. Italy Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Aphakia Market

  • 20.1. Spain Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Aphakia Market

  • 21.1. Eastern Europe Aphakia Market Overview
  • 21.2. Eastern Europe Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Aphakia Market

  • 22.1. Russia Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Aphakia Market

  • 23.1. North America Aphakia Market Overview
  • 23.2. North America Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Aphakia Market

  • 24.1. USA Aphakia Market Overview
  • 24.2. USA Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Aphakia Market

  • 25.1. Canada Aphakia Market Overview
  • 25.2. Canada Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Aphakia Market

  • 26.1. South America Aphakia Market Overview
  • 26.2. South America Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Aphakia Market

  • 27.1. Brazil Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Aphakia Market

  • 28.1. Middle East Aphakia Market Overview
  • 28.2. Middle East Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Aphakia Market

  • 29.1. Africa Aphakia Market Overview
  • 29.2. Africa Aphakia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Aphakia Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Aphakia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Aphakia Market Competitive Landscape And Company Profiles

  • 30.1. Aphakia Market Competitive Landscape
  • 30.2. Aphakia Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Aetna Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Alcon Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Hoya Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. CooperVision Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Aphakia Market Other Major And Innovative Companies

  • 31.1. Carl Zeiss AG
  • 31.2. Santen Pharmaceutical Co. Ltd.
  • 31.3. Appasamy Associates
  • 31.4. Aurolab
  • 31.5. Rayner Intraocular Lenses Limited
  • 31.6. VSY Biotechnology
  • 31.7. Ophtec BV
  • 31.8. SIFI SpA
  • 31.9. Aaren Scientific Inc.
  • 31.10. Mediphacos
  • 31.11. Hanita Lenses Ltd.
  • 31.12. Menicon Co. Ltd.
  • 31.13. Lenstec Inc.
  • 31.14. Morcher GmbH
  • 31.15. Bausch & Lomb Incorporated

32. Global Aphakia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aphakia Market

34. Recent Developments In The Aphakia Market

35. Aphakia Market High Potential Countries, Segments and Strategies

  • 35.1 Aphakia Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Aphakia Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Aphakia Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer